Log In
BCIQ
Print this Print this
 

BAN2203

  Manage Alerts
Collapse Summary General Information
Company BioArctic Neuroscience AB
DescriptionAlzheimer vaccine targeting a-synuclein
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsVaccinate against Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today